We previously identified SP as a key modulator of the steady state of HER2 and EGFR, with the functional consequence of enhanced tumor aggressiveness and tumor progression, and alterations in the cellular responses to apoptotic stimuli [27]. Here, ERBB2 is linked to neoplasm.